Acadian Asset Management LLC Uro Gen Pharma Ltd. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$8.84 - $22.64 $23,196 - $59,407	-2,624 Reduced 36.51%	4,563 $63,000
Q2 2023 Aug 07, 2023	BUY	$8.75 - $14.29 $22,960 - $37,496	2,624 Added 57.51%	7,187 $74,000
Q1 2023 May 11, 2023	BUY	$7.99 - $11.02 $36,458 - $50,284	4,563 New	4,563 $42,000
Q2 2018 Jul 24, 2018	SELL	$48.35 - $65.33 $256,980 - $347,228	-5,315 Closed	0 $0
Q1 2018 Apr 12, 2018	SELL	$38.64 - $57.54 $711,942 - $1.06 Million	-18,425 Reduced 77.61%	5,315 $264,000
Q4 2017 Jan 18, 2018	SELL	$27.28 - $43.26 $23,269 - $36,900	-853 Reduced 3.47%	23,740 $884,000
Q3 2017 Oct 13, 2017	BUY	$17.15 - $32.72 $421,769 - $804,682	24,593	24,593 $775,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $242M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.